122 related articles for article (PubMed ID: 25828281)
1. Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers.
Al-Qahtani KH; Al-Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Al-Hussain H; Maklad AM
Saudi Med J; 2015 Apr; 36(4):442-8. PubMed ID: 25828281
[TBL] [Abstract][Full Text] [Related]
2. Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma.
Lang BH; Lo CY; Wong IO; Cowling BJ
Surgery; 2010 Dec; 148(6):1191-6; discussion 1196-7. PubMed ID: 21134551
[TBL] [Abstract][Full Text] [Related]
3. "Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults".
Al-Qahtani KH; Tunio MA; Al Asiri M; Aljohani NJ; Bayoumi Y; Riaz K; AlShakweer W
J Otolaryngol Head Neck Surg; 2015 Nov; 44():48. PubMed ID: 26546329
[TBL] [Abstract][Full Text] [Related]
4. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?
Prommegger R; Ensinger C; Steiner P; Sauper T; Profanter C; Margreiter R
Anticancer Res; 2004; 24(2C):1049-51. PubMed ID: 15154621
[TBL] [Abstract][Full Text] [Related]
6. A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience.
Alhamadh MS; Alanazi RB; Algarni ST; Alhuntushi AAR; Alshehri MQ; Chachar YS; Alkaiyat M; Sabatin F
Curr Oncol; 2022 Jul; 29(7):4941-4955. PubMed ID: 35877253
[TBL] [Abstract][Full Text] [Related]
7. Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study.
Piscopo L; Volpe F; Nappi C; Zampella E; Manganelli M; Matrisciano F; Totaro P; Pace L; Maurea S; Cuocolo A; Klain M
Curr Oncol; 2022 Dec; 30(1):37-44. PubMed ID: 36661652
[TBL] [Abstract][Full Text] [Related]
8. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.
Vadgaonkar RA; Nayak SS; Doni S; Digumarti L; Mullapally SK; Digumarti R
Indian J Pathol Microbiol; 2021; 64(4):725-731. PubMed ID: 34673592
[TBL] [Abstract][Full Text] [Related]
10. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
13. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Beinart G; Gonzalez-Angulo AM; Broglio K; Mejia J; Ruggeri A; Mininberg E; Hortobagyi GN; Valero V
Clin Breast Cancer; 2007 Dec; 7(11):867-74. PubMed ID: 18269777
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.
Jones MS; Torisu-Itakura H; Flaherty DC; Schoellhammer HF; Lee J; Sim MS; Faries MB
Am Surg; 2016 Oct; 82(10):1009-1013. PubMed ID: 27779995
[TBL] [Abstract][Full Text] [Related]
16. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
18. Second primary malignancies in laryngeal carcinoma patients treated with definitive radiotherapy.
Ozdemir Y; Topkan E
Indian J Cancer; 2019; 56(1):29-34. PubMed ID: 30950440
[TBL] [Abstract][Full Text] [Related]
19. Co-occurrence of second primary malignancy in patients with thyroid cancer.
Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
[TBL] [Abstract][Full Text] [Related]
20. Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand.
Tangjitgamol S; Khunnarong J; Srijaipracharoen S
J Gynecol Oncol; 2015 Oct; 26(4):293-302. PubMed ID: 26197770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
